結核(TB)藥物耐藥是一個嚴重的公共健康問題。一種新型多藥耐藥結核(MDR-TB)診斷檢測只需要2天就能夠提供檢測結果。

這種新型檢測比傳統的檢測方法更快的提供結果，傳統方法需要數周才能夠給出檢測結果。MDR-TB的分子學檢測十分迅速，但是技術更復雜而且價格昂貴。FastPlaque-Response是由創新新型檢測FIND(Geneva, Switzerland)基金研制開發的，這是由Bill和Melinda Gates與Biotec Laboratories(Ipswich, UK)創建的。該檢測已經在歐洲注冊正在接受FIND的評估，以用于TB高流行的國家。

Rapid Test Detects Multi-Drug-Resistant TB
 
Tuberculosis (TB) drug resistance is a major public health problem. A new diagnostic test for multi-drug-resistant TB (MDR-TB) provides results in only two days.

The new test is much faster than conventional methods that take weeks to yield results. Molecular tests for MDR-TB are also rapid but are much more technically complicated and expensive. The FastPlaque-Response was developed by the Foundation for Innovative New Diagnostics FIND (Geneva, Switzerland), which is a Bill and Melinda Gates initiative, and Biotec Laboratories Ltd. (Ipswich, UK). The test has been registered in Europe and is in the process of being evaluated by FIND for use within the public health sector of countries where there is a high incidence of TB.